despit
declin
earli
death
rate
follow
intens
chemotherapi
acut
myeloid
leukemia
aml
patient
undergo
curativeint
therapi
remain
risk
treatmentrel
mortal
trm
given
individu
variat
trm
risk
interest
identifi
patient
highest
risk
possibl
assign
lowerintens
treatment
initi
studi
trm
predict
focus
patient
undergo
intens
chemotherapi
newli
diagnos
aml
effort
led
trm
score
ndtrm
score
multivari
measur
includ
age
perform
statu
diseas
type
primari
vs
secondari
aml
creatinin
white
blood
cell
wbc
count
peripher
blood
blast
percentag
platelet
count
albumin
adult
newli
diagnos
aml
treat
md
anderson
cancer
center
score
predict
death
within
day
treatment
initi
trm
good
accuraci
indic
area
receiv
oper
characterist
curv
auc
institut
ndtrm
score
sinc
serv
assign
patient
intens
nonintens
aml
therapi
although
deriv
patient
newli
diagnos
aml
also
use
relapsedrefractori
aml
diseas
test
abil
ndtrm
score
predict
earli
death
adult
relapsedrefractori
aml
evalu
covari
associ
earli
death
popul
via
electron
databas
identifi
adult
age
year
relapsedrefractori
aml
highgrad
md
blast
treat
institut
intens
chemotherapi
defin
treatment
intens
intens
standard
chemotherapi
ie
contain
cytarabin
daili
dose
mgm
januari
may
also
identifi
comparison
cohort
patient
age
year
newli
diagnos
aml
treat
intens
chemotherapi
time
period
demograph
clinic
laboratori
data
obtain
medic
record
studi
approv
institut
review
board
clinic
data
deidentifi
complianc
health
insur
portabl
account
act
hipaa
regul
trm
defin
death
day
treatment
initi
addit
use
death
within
day
death
within
day
altern
definit
earli
death
simplifi
ndtrm
score
calcul
previous
report
newli
diagnos
patient
covari
requir
calcul
ndtrm
score
collect
relapsedrefractori
patient
follow
addit
covari
collect
race
caucasian
noncaucasian
gender
cytogenet
risk
diagnosi
oxygen
requir
number
therapeut
ie
nonprophylact
antibiot
baselin
receipt
therapeut
antifung
baselin
number
prior
allogen
autolog
hematopoiet
cell
transplant
hct
durat
first
complet
remiss
durat
recent
cr
number
prior
intens
chemotherapi
cycl
time
sinc
recent
intens
chemotherapi
regimen
bilirubin
absolut
neutrophil
count
anc
hemoglobin
hgb
laboratori
valu
use
avail
one
week
less
prior
begin
treatment
valu
closest
start
treatment
chosen
conduct
logist
regress
analys
assess
relationship
individu
covari
trm
use
auc
quantifi
model
abil
predict
earli
death
gener
estim
equat
gee
regress
model
use
account
correl
within
patient
patient
may
sever
salvag
regimen
repres
dataset
one
patient
encount
select
covari
multivari
model
built
ridg
regress
model
outcom
includ
possibl
covari
outcom
fix
maximum
number
covari
includ
final
model
base
number
outcom
event
two
four
six
covari
trm
day
mortal
day
mortal
respect
covari
smallest
ridg
regress
pvalu
put
gee
model
estim
final
model
outcom
report
auc
bootstrap
time
account
model
select
procedur
method
auc
indic
poor
fair
good
predict
abil
respect
analys
perform
use
r
http
wwwrprojectorg
identifi
patient
relaps
refractori
aml
highrisk
md
treat
intens
chemotherapi
institut
januari
may
patient
suffici
data
avail
calcul
ndtrm
score
refractori
diseas
cycl
chemotherapi
relaps
diseas
tabl
among
patient
die
within
day
low
number
earli
death
patient
relaps
refractori
aml
analyz
one
cohort
still
ndtrm
model
perform
poorli
yield
auc
one
concern
poor
perform
relat
treatment
era
rather
relapsedrefractori
diseas
statu
model
develop
patient
treat
compar
cohort
patient
treat
therefor
identifi
patient
newli
diagnos
aml
treat
intens
induct
chemotherapi
among
patient
die
within
day
auc
ndtrm
score
sinc
might
hypothes
pretreat
patient
less
fit
examin
whether
relapsedrefractori
diseas
statu
independ
predictor
trm
combin
relapsedrefractori
patient
newli
diagnos
patient
yield
cohort
patient
auc
ndtrm
score
combin
group
includ
diseas
statu
chang
auc
odd
ratio
ci
covari
within
multivari
analysi
address
whether
trm
model
could
improv
relapsedrefractori
patient
addit
clinic
laboratori
covari
patient
complet
data
covari
requir
calcul
ndtrm
score
addit
covari
detail
within
subset
patient
die
within
day
treatment
initi
auc
ndtrm
score
univari
analys
identifi
sever
factor
statist
significantli
associ
day
mortal
includ
gender
femal
like
perform
statu
albumin
creatinin
peripher
blood
blast
percentag
oxygen
requir
durat
first
cr
univari
auc
covari
rang
supplement
tabl
sever
covari
overlap
found
import
newli
diagnos
aml
perform
statu
albumin
creatinin
peripher
blood
blast
percentag
support
relev
covari
predict
trm
follow
intens
therapi
also
identifi
factor
specif
patient
relapsedrefractori
aml
eg
durat
first
cr
rel
low
trm
rate
patient
cohort
rate
compar
report
recent
clinic
trial
limit
abil
build
complex
multivari
model
includ
covari
statist
signific
univari
analys
nonetheless
model
covari
perform
statu
creatinin
abl
predict
trm
rrtrm
score
auc
tabl
two
covari
ndtrm
model
chang
rel
weight
covari
account
auc
improv
compar
origin
trm
model
addit
mortal
also
investig
variabl
abil
predict
mortal
altern
definit
earli
death
subset
patient
complet
data
suffici
followup
data
day
respect
inclus
multivari
model
fourti
one
patient
die
day
die
day
treatment
initi
univari
analys
identifi
sever
covari
statist
significantli
associ
mortal
gender
diseas
type
perform
statu
albumin
oxygen
requir
auc
rang
mortal
diseas
type
perform
statu
albumin
creatinin
peripher
blood
blast
percentag
oxygen
requir
durat
first
recent
cr
auc
rang
supplement
tabl
multivari
rrtrm
model
predict
death
day
includ
number
covari
predict
power
similar
day
model
auc
respect
tabl
notabl
covari
consist
associ
earli
death
regardless
time
point
chosen
perform
statu
albumin
oxygen
requir
similar
covari
ndtrm
model
underscor
import
predict
trm
togeth
studi
identifi
covari
associ
earli
death
contemporari
aml
patient
undergo
treatment
relapsedrefractori
diseas
suggest
accur
predict
trm
multivari
model
possibl
despit
examin
rel
larg
patient
cohort
analys
limit
uncommon
occurr
trm
among
contemporari
patient
analysi
addit
larg
patient
cohort
treat
intens
chemotherapi
therefor
requir
develop
robust
predict
model
cohort
need
well
character
mani
covari
typic
avail
aml
patient
databas
confirm
find
describ
studi
could
improv
conduct
clinic
trial
relapsedrefractori
aml
provid
quantit
medic
fit
criteria
patient
select
refer
web
version
pubm
central
supplementari
materi
multivari
model
predict
mortal
trm
day
treatment
initi
